148 related articles for article (PubMed ID: 400733)
1. Diurnal 18-hydroxy-11-deoxycorticosterone pattern in human stable hypertension.
Sparano F; Sciarra F; Sulon J; Giaquinto G; Mercuri MA; Odoardi A; Tosticroce C; Genard P; Conti C
J Clin Endocrinol Metab; 1978 Oct; 47(4):829-33. PubMed ID: 400733
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
[No Abstract] [Full Text] [Related]
3. 24 hour profile of 18-hydroxy-11-deoxycorticosterone in normal supine man: relationship with cortisol and aldosterone.
Sulon J; Sparano F; Sciarra F; Giaquinto G; Genard P
Clin Endocrinol (Oxf); 1978 May; 8(5):367-72. PubMed ID: 565684
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
5. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Melby JC; Dale SL
Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
[TBL] [Abstract][Full Text] [Related]
6. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
Williams GH; Braley LM; Underwood RH
J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension.
Honda M; Den K; Kanbegawa A; Ueda Y; Tsuchiya M; Izumi Y; Oguri K; Shiratsuchi T; Hatano M
Endocrinol Jpn; 1978 Jun; 25(3):237-43. PubMed ID: 211025
[TBL] [Abstract][Full Text] [Related]
8. Urinary free 18-hydroxy-11-desoxycorticosterone excretion in normal and hypertensive patients.
Agrin RJ; Dale SL; Holbrook M; LaRossa JT; Melby JC
J Clin Endocrinol Metab; 1978 Oct; 47(4):877-84. PubMed ID: 233684
[TBL] [Abstract][Full Text] [Related]
9. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
[No Abstract] [Full Text] [Related]
10. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
Ojima M; Aida M; Kambegawa A
Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934
[TBL] [Abstract][Full Text] [Related]
11. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients.
Tosti-Croce C; Giaquinto G; Graziosi S; Odoardi A; Sparano F; Sciarra F
Horm Res; 1981; 15(1):28-36. PubMed ID: 6277757
[TBL] [Abstract][Full Text] [Related]
12. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
[TBL] [Abstract][Full Text] [Related]
13. 18-Hydroxy-11-deoxycorticosterone in hypertensive uremic patients during hemodialysis.
Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Tosti-Croce C; Sulon J; Sciarra F
Horm Res; 1979; 10(5):282-8. PubMed ID: 457038
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18-hydroxy-11-deoxycorticosterone, total and free cortisol and urinary corticosteroids.
Touitou Y; Sulon J; Bogdan A; Reinberg A; Sodoyez JC; Demey-Ponsart E
J Endocrinol; 1983 Jan; 96(1):53-64. PubMed ID: 6822782
[TBL] [Abstract][Full Text] [Related]
15. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic aspects of hypertension in Cushing's syndrome.
Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H
Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234
[TBL] [Abstract][Full Text] [Related]
17. Adrenal circadian system in young and elderly human subjects: a comparative study.
Touitou Y; Sulon J; Bogdan A; Touitou C; Reinberg A; Beck H; Sodoyez JC; Demey-Ponsart E; Van Cauwenberge H
J Endocrinol; 1982 May; 93(2):201-10. PubMed ID: 7086322
[TBL] [Abstract][Full Text] [Related]
18. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
Witzgall H; Thayil G; Weber PC
Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
[TBL] [Abstract][Full Text] [Related]
20. [Physiological regulation and clinical significance of 18-hydroxy-11-deoxycorticosterone].
Li G; Kuang AK; Ding T
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):94-7, 126. PubMed ID: 2985345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
